Rash: FDA reporting patterns
427,851 FDA FAERS reports mention Rash. 190,760 reports have a serious outcome flag.
Medicines named as suspect
- Dupilumab: 38,437 reports
- Adalimumab: 25,610 reports
- Etanercept: 20,314 reports
- Lenalidomide: 18,205 reports
- Methotrexate: 16,480 reports
- Adapalene: 15,991 reports
- Octisalate: 14,197 reports
- Avobenzone: 14,187 reports
- Infliximab: 13,766 reports
- Rituximab: 13,565 reports
- Tocilizumab: 13,052 reports
- Abatacept: 12,922 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.